BioAdaptives completes 1-for-300 reverse stock split effective Nov 21, 2024

BIOADAPTIVES, INC.

Reverse split reduces outstanding shares from ~1.23B to ~4.1M.
Split approved by shareholders on Sep 3, 2024; FINRA approved on Nov 20, 2024.
Company cites need to exit sub-penny trading, attract institutional investors, and support new company-owned products.
All new shares issued in book-entry form; fractional shares rounded based on decimal threshold.
Intended to be tax-free for U.S. federal income tax purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.